PROTECTIVE EFFECT AND ANTIBODY TITER OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) AGAINST CLINICAL ISOLATES OF OPPORTUNISTIC BACTERIA

被引:4
作者
NAKAE, T
NAKAJIMA, T
NAGAI, H
WATANABE, M
YOKOYAMA, K
机构
[1] Central Research Laboratories, Green Cross Corporation, Hirakata, Osaka 573
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 1994年 / 114卷 / 12期
关键词
IMMUNOGLOBULIN; OPPORTUNISTIC BACTERIA; INFECTION; ANTIBODY; PROTECTIVE ACTIVITY;
D O I
10.1248/yakushi1947.114.12_972
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neonates and leukopenic, immunosupressed patients are at high risk for severe infection of opportunistic pathogens despite of the availability of potent antimicrobial agents. In this study, antibody titers of immunoglobulin preparations (IVIG) were contrasted with the protective effect in mice against each of bacterial infection. Antibody titers were determined by ELISA. The antigens were 70-80 clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus, respectively. Antibody titers of IVIG against these three gram-negative bacteria ranged 3200 to 102400. ICR mice were inoculated intraperitoneally with each of several strains against which IVIG showed various titers. IVIG showed rather high protective activities against well-reactive strains, while it showed little protective activities against poor-reactive strains. In the case of P. aeruginosa, statistical analysis of the results obtained with the antibody titer and efficacy showed a good correlation (p<0.01). On the other hand, IVIG showed a high and complicate antibody titer against S. aureus IVIG ranging 400000 to 12800000, since apparent titers contained non-specific binding of Fc portion of IgG with protein A on the cell wall. IVIG was active in mice, where protein A was less and specific binding was stronger. Bacterial cells have various components; lipopolysaccharide, lipid A, capsule, flagella, pill, etc. that are responsive to specific antibodies. This study indicates that IVIG have such antibodies and that is associated with protective activity against bacterial infection in proportion to antibody titer.
引用
收藏
页码:972 / 979
页数:8
相关论文
共 18 条
[1]   CHARACTERIZATION OF MOUSE MONOCLONAL-ANTIBODIES PRODUCED BY IMMUNIZATION WITH A SINGLE SEROTYPE COMPONENT OF A POLYVALENT PSEUDOMONAS-AERUGINOSA VACCINE [J].
BARCLAY, GR ;
YAP, PL ;
MCCLELLAND, DBL ;
JONES, RJ ;
ROE, EA ;
MCCANN, MC ;
MICKLEM, LR ;
JAMES, K .
JOURNAL OF MEDICAL MICROBIOLOGY, 1986, 21 (01) :87-90
[2]  
DOI T, 1978, CHEM PHARM BULL, V26, P3492
[3]  
FURTH R, 1987, VOX SANG, V53, P70
[4]   GALACTOSAMINE-INDUCED SENSITIZATION TO THE LETHAL EFFECTS OF ENDOTOXIN [J].
GALANOS, C ;
FREUDENBERG, MA ;
REUTTER, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (11) :5939-5943
[5]   INFLUENCE OF THE ESCHERICHIA-COLI CAPSULE ON COMPLEMENT-FIXATION AND ON PHAGOCYTOSIS AND KILLING BY HUMAN PHAGOCYTES [J].
HORWITZ, MA ;
SILVERSTEIN, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (01) :82-94
[6]  
KIM KS, 1988, J INFECT DIS, V157, P4753
[7]  
LANDSPERGER WJ, 1987, LANCET, V1, P1035
[8]   PARTICIPATION OF IMMUNOGLOBULINS AND COMPLEMENT COMPONENTS IN THE INTRACELLULAR KILLING OF STAPHYLOCOCCUS-AUREUS AND ESCHERICHIA-COLI BY HUMAN-GRANULOCYTES [J].
LEIJH, PCJ ;
VANDENBARSELAAR, MT ;
DAHA, MR ;
VANFURTH, R .
INFECTION AND IMMUNITY, 1981, 33 (03) :714-724
[9]  
METHA ND, 1988, J MED MICROBIOL, V25, P85
[10]   POLYCLONAL AND MONOCLONAL-ANTIBODY THERAPY FOR EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PNEUMONIA [J].
PENNINGTON, JE ;
SMALL, GJ ;
LOSTROM, ME ;
PIER, GB .
INFECTION AND IMMUNITY, 1986, 54 (01) :239-244